{"doc_id": "si-2022-0043-reg-1", "parent_doc_id": "si-2022-0043", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "1. (1) These Regulations may be cited as the Medicinal Products (Control of", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products (Control of \n\nManufacture) (Amendment) Regulations 2022. \n\n(2) The Principal Regulations, the Regulations of 2009, the Medicinal \nProducts (Control of Manufacture) (Amendment) Regulations 2010 (S.I. No. \n288 of 2010), the Medicinal Products (Control of Manufacture) (Amendment) \nRegulations 2012 (S.I. No. 273 of 2012), the Regulations of 2013, Regulation 8 \nof the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I. \nNo. 36 of 2019), the Regulations of 2019 and these Regulations may be cited \ntogether as the Medicinal Products (Control of Manufacture) Regulations 2007 \nto 2022.", "text_norm": "1 (1) regulation may cited medicinal product (control manufacture) (amendment) regulation 2022 (2) principal regulation regulation 2009 medicinal product (control manufacture) (amendment) regulation 2010 (s.i no 288 2010) medicinal product (control manufacture) (amendment) regulation 2012 (s.i no 273 2012) regulation 2013 regulation 8 medicinal product (safety feature packaging) regulation 2019 (s.i no 36 2019) regulation 2019 regulation may cited together medicinal product (control manufacture) regulation 2007 2022", "start_char": 580, "end_char": 1250, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-2", "parent_doc_id": "si-2022-0043", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Control of Manufacture) \nRegulations 2007 (S.I. No. 539 of 2007); \n\n“Regulations of 2009” means the Medicinal Products (Control of Manufacture) \n(Amendment) Regulations 2009 (S.I. No. 4 of 2009); \n\n“Regulations of 2013” means the Medicinal Products (Control of Manufacture) \n(Amendment) Regulations 2013 (S.I. No. 163 of 2013); \n\n“Regulations of 2019” means the Medicinal Products (Control of Manufacture) \n(Amendment) Regulations 2019 (S.I. No 219 of 2019).", "text_norm": "2 regulations-- principal regulation mean medicinal product (control manufacture) regulation 2007 (s.i no 539 2007) regulation 2009 mean medicinal product (control manufacture) (amendment) regulation 2009 (s.i no 4 2009) regulation 2013 mean medicinal product (control manufacture) (amendment) regulation 2013 (s.i no 163 2013) regulation 2019 mean medicinal product (control manufacture) (amendment) regulation 2019 (s.i 219 2019)", "start_char": 1250, "end_char": 1794, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-3", "parent_doc_id": "si-2022-0043", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "3. Point 4 of the Arrangement of Regulations in the Principal Regulations", "text_raw": "3. Point 4 of the Arrangement of Regulations in the Principal Regulations \nis amended by substituting “auxiliary medicinal products” for “investigational \nmedicinal products”.", "text_norm": "3 point 4 arrangement regulation principal regulation amended substituting auxiliary medicinal product investigational medicinal product", "start_char": 1794, "end_char": 1972, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-4", "parent_doc_id": "si-2022-0043", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "4. Regulation 3(1) (as amended by Regulation 3 of the Regulations of 2013)", "text_raw": "4. Regulation 3(1) (as amended by Regulation 3 of the Regulations of 2013) \n\nof the Principal Regulations is amended— \n\n(a) by substituting for the definition of “Act” the following: \n\n“‘Act’ means the Irish Medicines Board Act 1995, as \namended by s. 197 of the Finance Act 1999 (No. 2 of 1999), \nRegulation 3 of the European Communities (In Vitro \nDiagnostic Medical Devices) Regulations 2001 (S.I. No. \n304 of 2001), Regulation 2 of the European Communities \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 4th February, 2022. \n\n \n \n \n \n \n \n \n \n\f[43] 3 \n\n(Medical Devices) (Amendment) Regulations 2001 (S.I. \n444 of 2001), Regulation 3 of the European Communities \n(Medical Devices) (Amendment) Regulations 2002 (S.I. \n576 of 2002), the Irish Medicines Board (Miscellaneous \nProvisions) Act 2006 (No. 3 of 2006), the European \nCommunities (Amendment of the Irish Medicines Board \nAct 1995) Regulations 2007 (S.I. No. 542 of 2007 ), the \nHealth (Pricing and Supply of Medical Goods) Act 2013 \n(No. 14 of 2013), the Health (Miscellaneous Provisions) \nAct 2017 (No. 1 of 2017) and the European Union (Medical \nDevices and In Vitro Diagnostic Medical Devices) \nRegulations 2017 (S.I. No. 547 of 2017);”, \n\n(b) by inserting after the definition of “Agency” the following \n\ndefinition: \n\n“‘authorised auxiliary medicinal product’ has the meaning \nassigned to it in Article 2(9) of the Clinical Trials \nRegulation;”, \n\n(c) \n\nby inserting after the definition of “authorised officer” the \nfollowing definition: \n\n“‘auxiliary medicinal product’ has the meaning assigned to \nit by Article 2(8) of the Clinical Trials Regulations;”, \n\n(d) by inserting after the definition of “certificate of traditional-use \n\nregistration” the following definition: \n\n“‘Clinical Trials Regulation’ means Regulation (EU) No \n536/2014 of the European Parliament and of the Council of \n16 April 2014;”, \n\n(e) \n\nin the definition of “2001 Directive” by substituting for “and \nDirective 2011/62/EU of the European Parliament and of the \nCouncil of 8 June 20111” the following: \n\n“, Directive 2011/62/EU of the European Parliament and of \nthe Council of 8 June 20111, Directive 2012/26/EU of the \nEuropean Parliament and of the Council of 25 October \n20122, Regulation (EU) 2017/745 of \nthe European \nParliament and of the Council of 5 April 20173, Regulation \n(EU) 2019/5 of the European Parliament and of the Council \nof 11 December 20184 and Regulation (EU) 2019/1243 of \nthe European Parliament and of the Council of 20 June \n20195”, \n\n(f) \n\nby substituting for the definition of “GMP Directive” the \nfollowing: \n\n1 OJ No. L 174, 1.7.2011, p. 74. \n2 OJ No. L 299, 27.10.2012, p. 1. \n3 OJ No. L 117, 5.5.2017, p. 1. \n4 OJ No. L 4, 7.1.2019, p. 24. \n5 OJ No. L 198, 25.7.2019, p. 241. \n\n \n \n\f4 [43] \n\n“‘GMP Directive’ means Commission Directive (EU) \n2017/1572 of 15 September 20176;”, \n\n(g) by substituting for the definition of “investigational medicinal \n\nproduct” the following: \n\n“‘investigational medicinal product’ has the meaning \nassigned to it by Article 2(5) of the Clinical Trials \nRegulations;”, \n\n(h) by substituting for the definition of “medicinal product” the \n\nfollowing: \n\n“‘medicinal product’ includes an auxiliary medicinal \nproduct but excludes an \ninvestigational medicinal \nproduct;”, \n\n(i) \n\nin the definition of “qualified person”— \n\n(i) \n\nby deleting “or” after subparagraph (b)(ii), and \n\n(ii) by deleting subparagraph (c), \n\n(j) \n\nin the definition of “Regulation (EC) No. 726/2004” by \nsubstituting for “and Regulation (EU) No. 1235/2010 of the \nEuropean Parliament and of the Council of 15 December 20107” \nthe following: \n\n(EU) No. 1027/2012 of \n\n“, Regulation (EU) No. 1235/2010 of the European \nParliament and of the Council of 15 December 20107, \nthe European \nRegulation \nParliament and of the Council of 25 October 20128, \nRegulation \nthe European \nParliament and of the Council of 14 November 20189 and \nRegulation (EU) No. 2019/5 of the European Parliament \nand the Council of 11 December 201810”, and \n\n(EU) No. 2018/1718 of \n\n(k) \n\nIn the definition of “Regulation (EU) 2016/161” by inserting “, as \namended by Commission Delegated Regulation (EU) 2021/457 \nof 13 January 202111” after “2 October 2015”.", "text_norm": "4 regulation 3(1) (as amended regulation 3 regulation 2013) principal regulation amended-- (a) substituting definition act following act mean irish medicine board act 1995 amended s 197 finance act 1999 (no 2 1999) regulation 3 european community (in vitro diagnostic medical devices) regulation 2001 (s.i no 304 2001) regulation 2 european community notice making statutory instrument published iris oifigiuil 4th february 2022 43 3 (medical devices) (amendment) regulation 2001 (s.i 444 2001) regulation 3 european community (medical devices) (amendment) regulation 2002 (s.i 576 2002) irish medicine board (miscellaneous provisions) act 2006 (no 3 2006) european community (amendment irish medicine board act 1995) regulation 2007 (s.i no 542 2007 ) health (pricing supply medical goods) act 2013 (no 14 2013) health (miscellaneous provisions) act 2017 (no 1 2017) european union (medical device vitro diagnostic medical devices) regulation 2017 (s.i no 547 2017) (b) inserting definition agency following definition authorised auxiliary medicinal product meaning assigned article 2(9) clinical trial regulation (c) inserting definition authorised officer following definition auxiliary medicinal product meaning assigned article 2(8) clinical trial regulation (d) inserting definition certificate traditional-use registration following definition clinical trial regulation mean regulation (eu) 536 2014 european parliament council 16 april 2014 (e) definition 2001 directive substituting directive 2011 62 eu european parliament council 8 june 20111 following directive 2011 62 eu european parliament council 8 june 20111 directive 2012 26 eu european parliament council 25 october 20122 regulation (eu) 2017 745 european parliament council 5 april 20173 regulation (eu) 2019 5 european parliament council 11 december 20184 regulation (eu) 2019 1243 european parliament council 20 june 20195 (f) substituting definition gmp directive following 1 oj no l 174 1.7.2011 p 74 2 oj no l 299 27.10.2012 p 1 3 oj no l 117 5.5.2017 p 1 4 oj no l 4 7.1.2019 p 24 5 oj no l 198 25.7.2019 p 241 4 43 gmp directive mean commission directive (eu) 2017 1572 15 september 20176 (g) substituting definition investigational medicinal product following investigational medicinal product meaning assigned article 2(5) clinical trial regulation (h) substituting definition medicinal product following medicinal product includes auxiliary medicinal product excludes investigational medicinal product (i) definition qualified person -- (i) deleting subparagraph (b)(ii) (ii) deleting subparagraph (c) (j) definition regulation (ec) no 726 2004 substituting regulation (eu) no 1235 2010 european parliament council 15 december 20107 following (eu) no 1027 2012 regulation (eu) no 1235 2010 european parliament council 15 december 20107 european regulation parliament council 25 october 20128 regulation european parliament council 14 november 20189 regulation (eu) no 2019 5 european parliament council 11 december 201810 (eu) no 2018 1718 (k) definition regulation (eu) 2016 161 inserting amended commission delegated regulation (eu) 2021 457 13 january 202111 2 october 2015", "start_char": 1972, "end_char": 6232, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-5", "parent_doc_id": "si-2022-0043", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "5. Regulation 11(6) of the Principal Regulations is amended by deleting “or", "text_raw": "5. Regulation 11(6) of the Principal Regulations is amended by deleting “or \nin the case of an authorisation relating to an investigational medicinal product, \nDirective 2001/20/EC12,”.", "text_norm": "5 regulation 11(6) principal regulation amended deleting case authorisation relating investigational medicinal product directive 2001 20 ec12", "start_char": 6232, "end_char": 6420, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-6", "parent_doc_id": "si-2022-0043", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "6. Regulation 13 (as amended by Regulation 2 of the Regulations of 2019)", "text_raw": "6. Regulation 13 (as amended by Regulation 2 of the Regulations of 2019) \n\nof the Principal Regulations is amended— \n\n6 OJ No. 238, 16.9.2017, p. 44. \n7 OJ No. L 348, 31.12.2010, p. 1. \n8 OJ No. L 316, 14.11.2012, p. 38. \n9 OJ No. L 291, 16.11.2018, p. 3. \n10 OJ No. L 4, 7.1.2019, p. 24. \n11 OJ No. L 91, 17.3.2021, p. 1. \n12 OJ No. L 121, 1.5.2001, p. 34. \n\n \n \n \n \n\f[43] 5 \n\n(a) \n\nin paragraph (3)— \n\n(i) \n\n(ii) \n\nin subparagraph (a) by deleting “investigational medicinal \nproducts and”, \n\nin subparagraph (b) by deleting “other than investigational \nmedicinal products,”, \n\n(iii) by deleting subparagraphs (c) to (e), and \n\n(iv) by renumbering subparagraph (f) as subparagraph (c) and \nsubstituting “subparagraph (a) or (b)” for “sub-paragraphs \n(a), (b), (c), (d) or (e)”, \n\n(b) \n\nin paragraph (4)— \n\n(i) \n\nin subparagraph (i) by substituting “The” for “(i) Except in \nthe case of investigational medicinal products, the”, and \n\n(ii) by deleting subparagraph (ii), and \n\n(c) \n\nin paragraph (8) by substituting “authorisation” for “licence”.", "text_norm": "6 regulation 13 (as amended regulation 2 regulation 2019) principal regulation amended-- 6 oj no 238 16.9.2017 p 44 7 oj no l 348 31.12.2010 p 1 8 oj no l 316 14.11.2012 p 38 9 oj no l 291 16.11.2018 p 3 10 oj no l 4 7.1.2019 p 24 11 oj no l 91 17.3.2021 p 1 12 oj no l 121 1.5.2001 p 34 43 5 (a) paragraph (3)-- (i) (ii) subparagraph (a) deleting investigational medicinal product subparagraph (b) deleting investigational medicinal product (iii) deleting subparagraphs (c) (e) (iv) renumbering subparagraph (f) subparagraph (c) substituting subparagraph (a) (b) sub-paragraphs (a) (b) (c) (d) (e) (b) paragraph (4)-- (i) subparagraph (i) substituting (i) except case investigational medicinal product (ii) deleting subparagraph (ii) (c) paragraph (8) substituting authorisation licence", "start_char": 6420, "end_char": 7469, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-9", "parent_doc_id": "si-2022-0043", "section_id": "reg-9", "section_label": "Regulation 9.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "9. Regulation 14B (inserted by Regulation 7 of the Regulations of 2013) of", "text_raw": "9. Regulation 14B (inserted by Regulation 7 of the Regulations of 2013) of \n\nthe Principal Regulations is amended by deleting paragraph (3).", "text_norm": "9 regulation 14b (inserted regulation 7 regulation 2013) principal regulation amended deleting paragraph (3)", "start_char": 7469, "end_char": 7612, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-10", "parent_doc_id": "si-2022-0043", "section_id": "reg-10", "section_label": "Regulation 10.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "10. Regulation 14C (inserted by Regulation 7 of the Regulations 2013) of", "text_raw": "10. Regulation 14C (inserted by Regulation 7 of the Regulations 2013) of \nthe Principal Regulations is amended by deleting paragraph (7) and renumbering \nparagraph (8) as paragraph (7).", "text_norm": "10 regulation 14c (inserted regulation 7 regulation 2013) principal regulation amended deleting paragraph (7) renumbering paragraph (8) paragraph (7)", "start_char": 7612, "end_char": 7800, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-11", "parent_doc_id": "si-2022-0043", "section_id": "reg-11", "section_label": "Regulation 11.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "11. Schedule 1 to the Principal Regulations is amended—", "text_raw": "11. Schedule 1 to the Principal Regulations is amended— \n\n(a) \n\n(b) \n\nin paragraph 7(1) by deleting “and address”, and \n\nin paragraph 7(2) by deleting “and address”.", "text_norm": "11 schedule 1 principal regulation amended-- (a) (b) paragraph 7(1) deleting address paragraph 7(2) deleting address", "start_char": 7800, "end_char": 7968, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-12", "parent_doc_id": "si-2022-0043", "section_id": "reg-12", "section_label": "Regulation 12.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "12. Schedule 2 (as amended by Regulation 2 of the Regulations of 2019) of", "text_raw": "12. Schedule 2 (as amended by Regulation 2 of the Regulations of 2019) of \n\nthe Principal Regulations is amended— \n\n(a) \n\nin paragraph 16 by deleting “investigational medicinal products \nor”, \n\n(b) \n\nin paragraph 20 by deleting subparagraph (2), \n\n(c) \n\nby substituting for paragraph 23(2)(d)the following: \n\n“(d) to auxiliary medicinal products \n\nin \naccordance with Article 59 of the Clinical Trials \nRegulation.” \n\nsupplied \n\n(d) \n\nin paragraph 34 by deleting “investigational medicinal products”.", "text_norm": "12 schedule 2 (as amended regulation 2 regulation 2019) principal regulation amended-- (a) paragraph 16 deleting investigational medicinal product (b) paragraph 20 deleting subparagraph (2) (c) substituting paragraph 23(2)(d)the following (d) auxiliary medicinal product accordance article 59 clinical trial regulation supplied (d) paragraph 34 deleting investigational medicinal product", "start_char": 7968, "end_char": 8471, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-reg-13", "parent_doc_id": "si-2022-0043", "section_id": "reg-13", "section_label": "Regulation 13.", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "13. Schedule 3 (as amended by Regulation 7 of the Regulations of 2009) of", "text_raw": "13. Schedule 3 (as amended by Regulation 7 of the Regulations of 2009) of \n\nthe Principal Regulations is amended— \n\n \n \n \n \n \n \n\f6 [43] \n\n(a) by substituting for paragraph 3(2) the following: \n\n“(2) The provisions of this paragraph shall not apply to \nauxiliary medicinal products supplied in accordance with \nArticle 59 of the Clinical Trails Regulations.”, \n\n(b) by deleting paragraph 7(3), and \n\n(c) \n\nby substituting for paragraph 12(2)(d) the following: \n\n“(d) to auxiliary medicinal products \n\nin \naccordance with Article 59 of the Clinical Trials \nRegulation.”. \n\nsupplied \n\nGIVEN under the Official Seal of the Minister for Health, \n\n31 January, 2022. \n\nMUIRIS O’CONNOR, \n\nA person authorised under section 15 of the Ministers and \nSecretaries Act 1924 to authenticate the seal of the Minister \nfor Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[43] 7", "text_norm": "13 schedule 3 (as amended regulation 7 regulation 2009) principal regulation amended-- 6 43 (a) substituting paragraph 3(2) following (2) provision paragraph shall apply auxiliary medicinal product supplied accordance article 59 clinical trail regulation (b) deleting paragraph 7(3) (c) substituting paragraph 12(2)(d) following (d) auxiliary medicinal product accordance article 59 clinical trial regulation  supplied given official seal minister health 31 january 2022 muiris connor person authorised section 15 minister secretary act 1924 authenticate seal minister health 43 7", "start_char": 8471, "end_char": 9326, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
{"doc_id": "si-2022-0043-explanatory-note", "parent_doc_id": "si-2022-0043", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 43 of 2022", "title": "of the Medicinal Products (Safety Features on Packaging) Regulations 2019 (S.I.", "year": 2022, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Control of Manufacture) \nRegulations 2007 (S.I. No. 539 of 2007) to remove investigational medicinal \nproducts from the scope of those Regulations. \n\n \n \n \n \n \n \n\f8 [43] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€3.00 \n\n(DH-375) 75. 2/22. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (control manufacture) regulation 2007 (s.i no 539 2007) remove investigational medicinal product scope regulation 8 43 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur3.00 (dh-375) 75 2 22 propylon", "start_char": 9326, "end_char": 10143, "source_path": "downloads\\2022\\2022_0042.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c646a9f8f19fde3524a6d1a16bea6b0a42d1d46640b92f9366cf8819a25497", "cross_refs": []}
